This brand name is authorized in Austria, Estonia.
The drug HYLASE DESSAU contains one active pharmaceutical ingredient (API):
1
|
UNII
8KOG53Z5EM - HYALURONIDASE (BOVINE)
|
|
Hyaluronidase is an enzyme that has a temporary and reversible depolymerising effect on the polysaccharide hyaluronic acid, which is present in the intercellular matrix of connective tissue. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B06AA03 | Hyaluronidase | B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AA Enzymes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1309980, 1848753 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.